> Diabetes Research > Ivabradine for Diabetes

Ivabradine for Diabetes

Posted on October 20, 2020 | No Comments on Ivabradine for Diabetes

Ivabradine is a revolutionary novel medication for the symptomatic management of stable angina pectoris or the chest pain caused by obstruction or spasm of the coronary arteries in the heart. It is marketed in different names such as Procoralan, Coralan, Corlentor, Coraxan and Ivabidand Bradia among others. The drug is essentially a cardiotonic agent that reduces the heart rate.

In a study by Borer JS, Tardif JC in the Howard Gilman Institute for Heart Valve Diseases, it discovered the efficacy and safety of ivabradine on glucose metabolism of patients with diabetes. Thus, the use of Ivabradine as treatment for angina of diabetic patients was shown to be effective. The Ivabradine drug is thus considered as an effective alternative for beta blockers in diabetic patients with stable angina pectoris.

In a similar study conducted by State University of New York Downstate Medical Center, Brooklyn and the Université de Montréal in Canada, researchers established effectiveness of ivabradine in reducing heart rate of people with diabetes and rebutted initial fears that the drug can increase the rates of sinus bradycardia or visual disturbances among diabetics. In a nutshell, scientific studies have validated the safety of Ivabradine for diabetic patients with of stable angina.

Related terms:

Related Posts:

» Tags: , , ,

Related terms:

Leave a Reply

Your email address will not be published. Required fields are marked *